SIGA Technologies CSO to Speak at The 13th CBRNe Protection Symposium on September 25, 2019
September 25, 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA to Present at the 14th Annual Wells Fargo Securities Healthcare Conference on September 5, 2019
August 28, 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Awarded Department of Defense Contract to Develop Expanded Indication for TPOXX® as Post-Exposure Prophylactic for Smallpox
July 08, 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA Technologies CEO to Speak at NCT Europe on June 27, 2019
June 18, 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Technologies to Host Business Update Webcast on June 18, 2019
June 11, 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, June 11, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...
SIGA Announces TPOXX® Promotion Agreement with Meridian Medical Technologies, Inc. (A Pfizer Company) for International Markets
June 03, 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA Announces Exercise of Option for the Purchase of Raw Materials for Oral TPOXX® Manufacturing Totaling $11 Million
May 20, 2019 16:30 ET
|
SIGA Technologies Inc.
Raw Materials expected to be used to Support Manufacture of 363,070 Courses of Oral TPOXX NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a...
SIGA to Present at the 8th Annual SVB Leerink Global Healthcare Conference on March 1, 2019
February 21, 2019 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Announces Priority Review Voucher Transaction Totaling $80 Million
November 01, 2018 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXX® as a Post-Exposure Prophylactic for Smallpox
October 04, 2018 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Oct. 04, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...